176 related articles for article (PubMed ID: 23277644)
1. Clinical application of recombinant human bone morphogenetic protein in cats and dogs: a review of 13 cases.
Pinel CB; Pluhar GE
Can Vet J; 2012 Jul; 53(7):767-74. PubMed ID: 23277644
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of recombinant human bone morphogenetic protein-2 in 4 dogs.
Milovancev M; Muir P; Manley PA; Seeherman HJ; Schaefer S
Vet Surg; 2007 Feb; 36(2):132-40. PubMed ID: 17335420
[TBL] [Abstract][Full Text] [Related]
3. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients.
Calori GM; Tagliabue L; Gala L; d'Imporzano M; Peretti G; Albisetti W
Injury; 2008 Dec; 39(12):1391-402. PubMed ID: 19027898
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats.
Schmoekel HG; Weber FE; Hurter K; Schense JC; Seiler G; Ryrz U; Spreng D; Schawalder P; Hubbell J
J Small Anim Pract; 2005 Jan; 46(1):17-21. PubMed ID: 15682735
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Assessment of Bone Regeneration in Nonunion Fractures Treated with Compression-Resistant Matrix and Recombinant Human Bone Morphogenetic Protein-2 in Dogs.
Castilla A; Filliquist B; Spriet M; Garcia TC; Arzi B; Chou PY; Kapatkin AS
Vet Comp Orthop Traumatol; 2023 Jan; 36(1):29-38. PubMed ID: 35760364
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein (BMP) for fracture healing in adults.
Garrison KR; Shemilt I; Donell S; Ryder JJ; Mugford M; Harvey I; Song F; Alt V
Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD006950. PubMed ID: 20556771
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions.
Haubruck P; Tanner MC; Vlachopoulos W; Hagelskamp S; Miska M; Ober J; Fischer C; Schmidmaier G
Orthop Traumatol Surg Res; 2018 Dec; 104(8):1241-1248. PubMed ID: 30293748
[TBL] [Abstract][Full Text] [Related]
8. Outcome of nonunion fractures in dogs treated with fixation, compression resistant matrix, and recombinant human bone morphogenetic protein-2.
Massie AM; Kapatkin AS; Fuller MC; Verstraete FJ; Arzi B
Vet Comp Orthop Traumatol; 2017 Mar; 30(2):153-159. PubMed ID: 28094415
[TBL] [Abstract][Full Text] [Related]
9. Treatment of a nonunion, secondary to gunshot fracture, of the distal radius with circular external fixation and rhBMP-2 in a cat.
Arnault F; Maitre P; Cachon T; Carozzo C; Fau D; Genevois JP; Viguier E
Vet Comp Orthop Traumatol; 2011; 24(4):289-93. PubMed ID: 21597648
[TBL] [Abstract][Full Text] [Related]
10. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7.
Dahabreh Z; Dimitriou R; Giannoudis PV
Injury; 2007 Mar; 38(3):371-7. PubMed ID: 17070526
[TBL] [Abstract][Full Text] [Related]
11. Application of recombinant BMP-7 on persistent upper and lower limb non-unions.
Dimitriou R; Dahabreh Z; Katsoulis E; Matthews SJ; Branfoot T; Giannoudis PV
Injury; 2005 Nov; 36 Suppl 4():S51-9. PubMed ID: 16291324
[TBL] [Abstract][Full Text] [Related]
12. Comparative study suggests that human bone morphogenetic proteins have no influence on the outcome of operative treatment of aseptic clavicle non-unions.
von Rüden C; Morgenstern M; Friederichs J; Augat P; Hackl S; Woltmann A; Bühren V; Hierholzer C
Int Orthop; 2016 Nov; 40(11):2339-2345. PubMed ID: 27520739
[TBL] [Abstract][Full Text] [Related]
13. Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix.
Schmökel HG; Weber FE; Seiler G; von Rechenberg B; Schense JC; Schawalder P; Hubbell J
Vet Surg; 2004; 33(2):112-8. PubMed ID: 15027972
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human bone morphogenetic proteins in the treatment of fractures.
Kain MS; Einhorn TA
Foot Ankle Clin; 2005 Dec; 10(4):639-50, viii. PubMed ID: 16297824
[TBL] [Abstract][Full Text] [Related]
15. Regenerating Mandibular Bone Using rhBMP--2: Part 2-Treatment of Chronic, Defect Non-Union Fractures.
Verstraete FJ; Arzi B; Huey DJ; Cissell DD; Athanasiou KA
Vet Surg; 2015 May; 44(4):410-6. PubMed ID: 24410723
[TBL] [Abstract][Full Text] [Related]
16. The treatment of atrophic, recalcitrant long-bone nonunion in the upper extremity with human recombinant bone morphogenetic protein-7 (rhBMP-7) and plate fixation: A retrospective review.
Morison Z; Vicente M; Schemitsch EH; McKee MD
Injury; 2016 Feb; 47(2):356-63. PubMed ID: 26763298
[TBL] [Abstract][Full Text] [Related]
17. Safety profile for the clinical use of bone morphogenetic proteins in the spine.
Poynton AR; Lane JM
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S40-8. PubMed ID: 12205419
[TBL] [Abstract][Full Text] [Related]
18. RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation.
Ristiniemi J; Flinkkilä T; Hyvönen P; Lakovaara M; Pakarinen H; Jalovaara P
J Bone Joint Surg Br; 2007 Feb; 89(2):265-72. PubMed ID: 17322450
[TBL] [Abstract][Full Text] [Related]
19. No advantage to rhBMP-2 in addition to autogenous graft for fracture nonunion.
Takemoto R; Forman J; Taormina DP; Egol KA
Orthopedics; 2014 Jun; 37(6):e525-30. PubMed ID: 24972432
[TBL] [Abstract][Full Text] [Related]
20. Role of Recombinant Human Bone Morphogenetic Protein-2 on Hindfoot Arthrodesis.
Hreha J; Krell ES; Bibbo C
Foot Ankle Clin; 2016 Dec; 21(4):793-802. PubMed ID: 27871412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
